Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT03972657
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Mayo Clinic Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
NCT07188896
- Conditions
- Adenocarcinoma, Advanced Renal Cell Carcinoma (aRCC), Carcinoma, +16 more
- Locations
-
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
- Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors
NCT05176483
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Exelixis Clinical Site #67 Phoenix, Arizona, United States
- Exelixis Clinical Site #1 Tucson, Arizona, United States
- Exelixis Clinical Site #123 Palo Alto, California, United States
- Exelixis Clinical Site #59 Santa Barbara, California, United States
NCT06026410
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +37 more
- Locations
-
- Mayo Clinic Comprehensive Cancer Center Phoenix, Arizona, United States
- University of Arizona Tucson, Arizona, United States
- University of Southern California Los Angeles, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
NCT07386158
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Other (Non U.s.), China
NCT06916624
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
Not Yet Recruiting
CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC
NCT07077083
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT07594106
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
Not specified
Completed
A Study to Evaluate the Safety and Dosimetry of 68Ga-OncoCAIX in Patients With CAIX-positive Cancer
NCT06840548
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- ASST Papa Giovanni XXIII Bergamo, BG, Italy
- IRCCS Ospedale San Raffaele Milan, Milano, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milano, Italy
NCT06778538
- Conditions
- Adenocarcinoma, Carcinogenesis, Carcinoma, +18 more
- Locations
-
- Lanzhou University Second Hospital Lanzhou, Gansu, China
Active, Not Recruiting
A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)
NCT03634540
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +26 more
- Locations
-
- USC Norris Comprehensive Cancer Center ( Site 0060) Los Angeles, California, United States
- Cedars Sinai Medical Center Samuel Oschin Comp. Cancer Institute ( Site 0003) Los Angeles, California, United States
- Sylvester Comprehensive Cancer Center ( Site 0023) Miami, Florida, United States
- Dana Farber Cancer Center ( Site 0006) Boston, Massachusetts, United States